The Influence of Treatment Format on Schema Therapy for Borderline Personality Disorder
Enrolling by invitation · Not applicable
Conditions studied: Borderline Personality Disorder
In brief
The goal of this clinical trial is to compare etc. in patients with borderline personality disorder pure individual schema therapy to combined individual-group schema therapy. The main questions it aims to answer are: * is there a difference in effectiveness? * is there a difference in (early) treatment dropout? Participants will receive either * individual schema therapy or * combined individual-group schema therapy. Researchers will compare individual to combined individual-group schema therapy see if there is a difference in effects and/or a difference in dropout from treatment.
Key facts
- Study ID
- NCT05986552
- Run by
- University of Amsterdam
- People needed
- 132
- Starts
- 2023-11-10
- Expected to finish
- 2030-08-30
- Last updated by the study team
- 2026-05-06
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- BPD as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), assessed with the Structured Clinical Interview for the DSM-5 Personality Disorders (SCID-5-PD), as primary diagnosis
- BPDSI total score ≥ 20 (i.e, severity in the BPD range, Giesen-Bloo et al., 2010)
- Ability to understand, read, write and speak Dutch, or English if the site has research assistants and therapists of both conditions that are sufficiently fluent in English, as well as an English ST group (as at ACTP).
You may not qualify if…
- DSM-5 substance use disorder that needs clinical detox according to the clinical staff (after 6 weeks of abstinence participation is possible).
- Comorbid psychotic disorder (patients with temporary psychotic problems falling under BPD criterion 9 are not excluded)
- DSM-5 Bipolar disorder, type 1 (current or past)
- Acute suicide risk
- Intelligence Quotient (IQ) < 80
- Serious neurological problems such as dementia
- Patients should not start with any form of psychological treatment during screening or during the study's waitlist or treatment. (Low frequency supportive treatment may be continued during wait and screening, but not during the study treatment.)
- Not able or willing to plan participation in the treatment sessions. Note 1. In case of suspicion of exclusion criteria that need specific assessment, like IQ and dementia, a formal diagnostic assessment needs to be done before in/exclusion can be decided.
- Note 2. No other psychological treatment during the study follow-up period is provided, unless this is necessary (clinical judgment). The 1 year treatment-free follow-up period is part of the treatment protocol, to help patients gain experience with life without mental health care. After 1 year further treatment can be offered, if indicated.
Where it is running
- Academic Center for Trauma and Personality ACTP — Amsterdam, Netherlands
- Arkin Mental Health Care — Amsterdam, Netherlands
- GGZ Oost-Brabant — Helmond, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.